Indication
Primitive
4 clinical trials
5 products
1 drug
Product
ONC206Clinical trial
A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Pediatric Solid TumorsStatus: Completed, Estimated PCD: 2023-12-27
Product
Metronomic CyclophosphamideProduct
ThalidomideClinical trial
A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive ChemotherapyStatus: Terminated, Estimated PCD: 2021-09-01
Product
GenisteinDrug
VarlilumabClinical trial
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsStatus: Active (not recruiting), Estimated PCD: 2025-09-01
Product
G207